Skip to main content

Hit enter to search or ESC to close

Products
Careers
Contact
About

Monthly Archives

March 2022

News

Padagis Announces the FDA Approval and Launch of an AB Rated Generic Version of Tobradex® Ophthalmic Suspension

Recent Posts

Pam Hoffman promoted to President
Padagis announces the relaunch of Bacitracin Ophthalmic Ointment
Padagis announces the launch of Brimonidine Topical Gel, 0.33%
Padagis announces the relaunch of Evamist® (estradiol transdermal spray)
Letter to Pharmacists concerning red dye #40

Recent Comments

© Padagis®. All Rights Reserved.

Patent Resources

Terms and Conditions

Privacy Statement

Products
Careers
Contact
About